Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01648166 · ClinicalTrials.gov registry record
Study of Lung Cancer in Appalachian Kentucky: The Role of Environmental Carcinogens
A clinical trial, sponsored by Susanne Arnold.
- Completed
- Registry status
- 520
- Enrollment target
NCT01648166: Completed study, sponsored by Susanne Arnold.
NCT01648166 is a clinical trial that has completed, run by Susanne Arnold. The registered enrollment target is 520 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01648166 has completed, sponsored by Susanne Arnold.
- COMPLETED
- Registry status
- 520 participants
- Enrollment target
Study Summary
This is a research study about the relationship between lung cancer and environmental risk factors. The purpose of this study is to try to understand the effects of trace elements such as arsenic and chromium, as well as radon on the development of lung cancer. To do this, the investigators will collect information and environmental and biologic specimens from people who live in Appalachian Kentucky who a) have lung cancer or b) don't have lung cancer and will serve as control subjects. The investigators will create a specimen repository of from these people and their residences to compare differences in many risks factors for cancer. By doing this study, the investigators hope to learn why there are more lung cancers in Kentucky's fifth Congressional District than anywhere else in the nation.
Primary Outcome
Conduct a case-control study of lung cancer and matched controls in the 5th Congressional District of Kentucky to compare rates of moderate to high arsenic in lung cancer cases and controls (primary endpoint).
Interventions
- OTHER Environmental sampling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 520 participants |
| Start Date | 2011-09 |
| Est. Completion | 2019-09-04 |
What the finished NCT01648166 record still lists
NCT01648166 is an observational study that tracks outcomes without assigning an intervention. The registered 520 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Environmental sampling is the first listed.
NCT01648166 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01648166 about?
NCT01648166 is a clinical study titled "Study of Lung Cancer in Appalachian Kentucky: The Role of Environmental Carcinogens". This is a research study about the relationship between lung cancer and environmental risk factors. The purpose of this study is to try to understand the effects of trace elements such as arsenic and chromium, as well as radon on the development of lung cancer. To do this, the investigators will col...
What is the current status of trial NCT01648166?
This trial is currently completed. The enrollment target is 520 participants. The study started on 2011-09. Estimated completion is 2019-09-04.
What interventions are being tested in trial NCT01648166?
The interventions under investigation include: Environmental sampling (OTHER).
Who is sponsoring clinical trial NCT01648166?
This trial is sponsored by Susanne Arnold, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323581 · 520 participants · NA
Endovascular Treatment of TAAA and Aortic Arch Aneurysms Using Fenestrated and Branched Stent Grafts
- NCT04656496 · 520 participants · NA
NOURISH-T+: Promoting Healthy Eating and Exercise Behaviors
- NCT05445778 · 520 participants · Phase 3
Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer
- NCT05498428 · 520 participants · Phase 2
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia